Oxford’s Organox Raises A £25 Million Profusion To Expand Its Commercial Footprint And Make Transplant Organs More Widely Available

Jul 17, 2023•about 2 years ago

Amount Raised

£25 Million

OxfordshireBiotechnologyHealth Care

Investors

Lauxera Capital Partners

Description

Oxford-based medtech firm OrganOx has raised £25 million in growth investment as it looks to expand its commercial footprint. The company was founded in Oxford, as a spin out of the university, in 2008 – it says this growth funding is a step in the direction of getting its ducks in a row for an IPO.

Company Information

Company

OrganOx Limited

Location

Oxfordshire, England, United Kingdom

About

OrganOx Limited is a medical technology company dedicated to improving organ transplant outcomes through its advanced organ preservation solutions. The company develops devices that enhance the viability and health of organs before transplantation. Their expertise is primarily in the preservation of livers for transplant procedures. OrganOx aims to bridge the gap between organ donation and transplantation.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends